Pharma Focus Asia

Dr Reddy's buys 6 OTC brands from US-based Ducere Pharma

Thursday, May 26, 2016

Drug major Dr Reddy's Laboratories has forayed into branded consumer health products segment in the US market by acquiring six over-the-counter (OTC) brands from Ducere Pharma for an undisclosed amount.

The brands acquired include Doan's, Bufferin, Nupercainal ointment, Cruex nail gel, comtrex and myoflex. These are mainly used in treating cough-and-cold, pain and dermatology issues.

"We are extremely excited to be entering the branded consumer health arena through these brands and embarking upon the next avenue of growth for our OTC business in the US," Executive Vice-President and Head of Dr Reddy's in the US Alok Sonig said.

These legacy products enjoy strong brand equity built over several decades, he added.

Dr Reddy's will build upon the sales and marketing efforts for these brands and continue to focus on their expansion into existing and new market channels, Sonig said.

Dr Reddy's shares today ended 0.92 per cent higher at Rs 3,052.95 apiece on BSE.

 

Source : economictimes.indiatimes.com

magazine-slider-imageMFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopNitrosamine Advance Workshop 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024